Literature DB >> 6418573

Serum luteinizing hormone during ovulation induction with human menopausal gonadotropin for in vitro fertilization in normally menstruating women.

A P Ferraretti, J E Garcia, A A Acosta, G S Jones.   

Abstract

Sixteen cycles in 14 normally menstruating women, stimulated with human menopausal gonadotropin in order to recruit more than one follicle for a successful in vitro fertilization process, were adequately monitored to identify the appearance of the spontaneous luteinizing hormone (LH) surge. Daily serum LH determinations, increased to every 4 hours in the presumptive preovulatory period, showed that in these women the endogenous estrogen-triggered LH midcycle peak did not occur at the expected time. It is hypothesized that the mechanism responsible for this suppression is a negative feedback mediated by an increased circulating protein with an inhibin-like action.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418573     DOI: 10.1016/s0015-0282(16)47473-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

Review 1.  Drugs used in in vitro fertilisation procedures.

Authors:  I E Messinis
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

2.  [Spontaneous endogenous LH increase in the stimulated cycle].

Authors:  H Alexander; M Birkhäuser; G Zimmermann; P Huber; N Pavic; M Lehmann; D Baier; W Weber; K W Haake
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 3.  Progress in ovulation induction with gonadotropins.

Authors:  P R Gindoff; R Jewelewicz
Journal:  Bull N Y Acad Med       Date:  1989-06

Review 4.  Gonadotropin surge-inhibiting/attenuating factors: a review of current evidence, potential applications, and future directions for research.

Authors:  Mario G Vega; Shvetha M Zarek; Medha Bhagwat; James H Segars
Journal:  Mol Reprod Dev       Date:  2015-01-12       Impact factor: 2.609

5.  Clinical aspects with regard to the occurrence of an endogenous luteinizing hormone surge in gonadotropin-induced normal menstrual cycles.

Authors:  J F Van Uem; J E Garcia; H C Liu; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-12

6.  The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization.

Authors:  D Navot; Z Rosenwaks
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

7.  Preferred protocol: controlled ovarian stimulation.

Authors:  H W Jones
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

8.  In vitro fertilization in Norfolk, Virginia, 1980-1983.

Authors:  J Garcia; A Acosta; M C Andrews; G S Jones; H W Jones; T Mantzavinos; J Mayer; J McDowell; B Sandow; L Veeck
Journal:  J In Vitro Fert Embryo Transf       Date:  1984-03

9.  Endogenous luteinizing hormone release using human menopausal gonadotropins for in vitro fertilization.

Authors:  J M Vargyas; R P Marrs
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-04

10.  Effectiveness of short pituitary suppression with gonadotropin-releasing hormone agonist leuprolide during induction of ovulation for in vitro fertilization.

Authors:  I Henig; P J Chan; S G Prough; D R Tredway
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.